BE2015C068I2 - - Google Patents

Download PDF

Info

Publication number: BE2015C068I2
Authority: BE; Belgium

Application number

BE2015C068C

Other languages

French (fr)

Original Assignee

Glaxosmithkline Biologicals Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-20

Filing date

2015-12-09

Publication date

2024-08-08

2015-12-09 Application filed by Glaxosmithkline Biologicals Sa filed Critical Glaxosmithkline Biologicals Sa

2024-08-08 Publication of BE2015C068I2 publication Critical patent/BE2015C068I2/fr

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5258—Virus-like particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20023—Virus like particles [VLP]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Virology (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Microbiology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biochemistry (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Biophysics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

BE2015C068C 2002-12-20 2015-12-09 BE2015C068I2 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43503502P	2002-12-20	2002-12-20
US49665303P	2003-08-20	2003-08-20

Publications (1)

Publication Number	Publication Date
BE2015C068I2 true BE2015C068I2 (de)	2024-08-08

Family

ID=32685362

Family Applications (3)

Application Number	Title	Priority Date
BE2015C069C BE2015C069I2 (de)	2002-12-20	2015-12-09
BE2015C068C BE2015C068I2 (de)	2002-12-20	2015-12-09
BE2015C067C BE2015C067I2 (de)	2002-12-20	2015-12-09

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
BE2015C069C BE2015C069I2 (de)	2002-12-20	2015-12-09

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BE2015C067C BE2015C067I2 (de)	2002-12-20	2015-12-09

Country Status (28)

Country	Link
US (2)	US20060251676A1 (de)
EP (1)	EP1572233B1 (de)
JP (1)	JP5475939B2 (de)
KR (3)	KR101361769B1 (de)
AP (1)	AP2005003347A0 (de)
AR (1)	AR042530A1 (de)
AT (1)	ATE503492T1 (de)
AU (1)	AU2003293942B2 (de)
BE (3)	BE2015C069I2 (de)
BR (1)	BR0317544A (de)
CA (1)	CA2510457C (de)
CY (1)	CY1111552T1 (de)
DE (1)	DE60336581D1 (de)
DK (1)	DK1572233T3 (de)
EA (2)	EA200701633A1 (de)
EC (1)	ECSP055869A (de)
IL (1)	IL169085A (de)
IS (1)	IS2811B (de)
MA (1)	MA27581A1 (de)
MX (1)	MXPA05006764A (de)
MY (1)	MY144492A (de)
NO (1)	NO20052846L (de)
NZ (1)	NZ540811A (de)
OA (1)	OA13147A (de)
PL (1)	PL215257B1 (de)
PT (1)	PT1572233E (de)
TW (1)	TWI349557B (de)
WO (1)	WO2004056389A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI1126876T1 (sl)	1998-10-16	2007-08-31	Glaxosmithkline Biolog Sa	Adjuvantni sistemi in vakcine
GB0206360D0 (en)	2002-03-18	2002-05-01	Glaxosmithkline Biolog Sa	Viral antigens
US7858098B2 (en)	2002-12-20	2010-12-28	Glaxosmithkline Biologicals, S.A.	Vaccine
US7758866B2 (en)	2004-06-16	2010-07-20	Glaxosmithkline Biologicals, S.A.	Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
RU2420313C2 (ru) *	2004-06-16	2011-06-10	ГлаксоСмитКлайн Байолоджикалз с.а.	Вакцина против вирусов папилломы человека hpv 16 и hpv 18 и по меньшей мере еще одного типа hpv, выбранного из hpv 31, 45 или 52
EP1877087B1 (de)	2005-04-15	2013-02-20	GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES	Verfahren und zusammensetzungen zur erzeugung einer verbesserten immunantwort auf ein menschliches papillomavirus-immunogen
MX2007013472A (es) *	2005-04-26	2008-04-02	Glaxosmithkline Biolog Sa	Vacuna.
MX2007013475A (es) *	2005-04-26	2008-04-02	Glaxosmithkline Biolog Sa	Vacuna.
CN101570571B (zh)	2007-04-29	2012-07-11	北京万泰生物药业股份有限公司	截短的人乳头瘤病毒18型l1蛋白
CN101293918B (zh)	2007-04-29	2013-03-27	北京万泰生物药业股份有限公司	截短的人乳头瘤病毒16型l1蛋白
EP2403507B1 (de) *	2009-03-05	2018-02-21	McCloskey, Jenny Colleen	Behandlung von infektionen
CN102215861B (zh) *	2009-06-19	2014-10-08	艾金株式会社	宫颈癌疫苗
CN106461667A (zh)	2014-01-31	2017-02-22	乌利塞生物医药公司	用于检测感染及相关病症的生物传感器
CN107001430A (zh)	2014-10-24	2017-08-01	哈普威克斯有限责任公司	癌症和皮肤病变治疗
US10799574B2 (en)	2014-10-24	2020-10-13	Hpvvax. Llc	Method and composition for treating cancer or skin lesion using a vaccine
CA2987864C (en) *	2015-06-02	2020-08-18	Terumo Kabushiki Kaisha	Adjuvant composition containing aluminum and vaccine composition containing the same
IL277128B2 (en)	2018-03-06	2025-11-01	Precigen Inc	Hepatitis b vaccines and uses of the same
JP7581048B2 (ja) *	2018-03-06	2024-11-12	プレシゲン，インコーポレイテッド	ヒトパピローマウイルスワクチンおよびその使用
US11771754B2 (en) *	2018-06-04	2023-10-03	Xiamen University	Mutant of L1 protein of human papillomavirus type 18
EP3891123A4 (de)	2018-12-03	2022-12-14	Board of Regents, The University of Texas System	Oligo-benzamid-analoge und ihre verwendung zur behandlung von krebs

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4332596A1 (de) *	1993-09-24	1995-03-30	Martin Josef Dr Sapp	Monoklonale Antikörper
ES2572628T3 (es)	1997-09-05	2016-06-01	Medimmune, Inc.	Método in vitro para desmontaje/remontaje de partículas análogas al virus del papiloma humano (VLP)
DE60040727D1 (de) *	1999-02-05	2008-12-18	Merck & Co Inc	Menschliche papillomavirus impfstoff-formulierungen
US6245568B1 (en)	1999-03-26	2001-06-12	Merck & Co., Inc.	Human papilloma virus vaccine with disassembled and reassembled virus-like particles
GB9921146D0 (en) *	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
US6908613B2 (en) *	2000-06-21	2005-06-21	Medimmune, Inc.	Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
PT1296711E (pt) *	2000-06-26	2006-08-31	Stressgen Biotechnologies Corp	E7 de vph para o tratamento do virus do papiloma humano

2003
- 2003-12-18 MX MXPA05006764A patent/MXPA05006764A/es active IP Right Grant
- 2003-12-18 KR KR1020127027784A patent/KR101361769B1/ko not_active Expired - Lifetime
- 2003-12-18 KR KR1020057011497A patent/KR20050086924A/ko not_active Ceased
- 2003-12-18 MY MYPI20034868A patent/MY144492A/en unknown
- 2003-12-18 US US10/540,099 patent/US20060251676A1/en not_active Abandoned
- 2003-12-18 AR ARP030104709A patent/AR042530A1/es unknown
- 2003-12-18 NZ NZ540811A patent/NZ540811A/en not_active IP Right Cessation
- 2003-12-18 OA OA1200500189A patent/OA13147A/en unknown
- 2003-12-18 BR BR0317544-8A patent/BR0317544A/pt not_active Application Discontinuation
- 2003-12-18 AP AP2005003347A patent/AP2005003347A0/xx unknown
- 2003-12-18 AT AT03789346T patent/ATE503492T1/de active
- 2003-12-18 WO PCT/EP2003/014562 patent/WO2004056389A1/en not_active Ceased
- 2003-12-18 EP EP03789346A patent/EP1572233B1/de not_active Expired - Lifetime
- 2003-12-18 CA CA2510457A patent/CA2510457C/en not_active Expired - Lifetime
- 2003-12-18 EA EA200701633A patent/EA200701633A1/ru unknown
- 2003-12-18 TW TW092135963A patent/TWI349557B/zh not_active IP Right Cessation
- 2003-12-18 DK DK03789346.8T patent/DK1572233T3/da active
- 2003-12-18 EA EA200500834A patent/EA009179B1/ru not_active IP Right Cessation
- 2003-12-18 KR KR1020127026719A patent/KR20120118087A/ko not_active Withdrawn
- 2003-12-18 DE DE60336581T patent/DE60336581D1/de not_active Expired - Lifetime
- 2003-12-18 AU AU2003293942A patent/AU2003293942B2/en not_active Expired
- 2003-12-18 PL PL377710A patent/PL215257B1/pl unknown
- 2003-12-18 JP JP2005502554A patent/JP5475939B2/ja not_active Expired - Lifetime
- 2003-12-18 PT PT03789346T patent/PT1572233E/pt unknown
2005
- 2005-04-26 US US11/114,301 patent/US20050287161A1/en not_active Abandoned
- 2005-06-09 IL IL169085A patent/IL169085A/en active IP Right Grant
- 2005-06-09 IS IS7885A patent/IS2811B/is unknown
- 2005-06-13 NO NO20052846A patent/NO20052846L/no not_active Application Discontinuation
- 2005-06-20 EC EC2005005869A patent/ECSP055869A/es unknown
- 2005-07-18 MA MA28398A patent/MA27581A1/fr unknown
2011
- 2011-06-08 CY CY20111100549T patent/CY1111552T1/el unknown
2015
- 2015-12-09 BE BE2015C069C patent/BE2015C069I2/fr unknown
- 2015-12-09 BE BE2015C068C patent/BE2015C068I2/fr unknown
- 2015-12-09 BE BE2015C067C patent/BE2015C067I2/fr unknown

Also Published As

Publication number	Publication date
BE2015C067I2 (de)	2024-08-08
MA27581A1 (fr)	2005-10-03
AU2003293942B2 (en)	2009-12-10
DE60336581D1 (de)	2011-05-12
WO2004056389A1 (en)	2004-07-08
BR0317544A (pt)	2005-11-22
NO20052846L (no)	2005-07-13
MY144492A (en)	2011-09-30
KR20120123616A (ko)	2012-11-08
CA2510457A1 (en)	2004-07-08
DK1572233T3 (da)	2011-06-27
EA200701633A1 (ru)	2007-12-28
CA2510457C (en)	2011-12-06
KR101361769B1 (ko)	2014-02-10
KR20050086924A (ko)	2005-08-30
PL377710A1 (pl)	2006-02-06
TWI349557B (en)	2011-10-01
EA200500834A1 (ru)	2006-02-24
JP2006512413A (ja)	2006-04-13
ATE503492T1 (de)	2011-04-15
JP5475939B2 (ja)	2014-04-16
NZ540811A (en)	2007-03-30
IL169085A (en)	2014-04-30
MXPA05006764A (es)	2005-09-08
PT1572233E (pt)	2011-06-07
AU2003293942A1 (en)	2004-07-14
IS2811B (is)	2012-11-15
PL215257B1 (pl)	2013-11-29
KR20120118087A (ko)	2012-10-25
ECSP055869A (es)	2005-09-20
US20050287161A1 (en)	2005-12-29
AP2005003347A0 (en)	2005-06-30
IL169085A0 (en)	2007-07-04
HK1085378A1 (en)	2006-08-25
BE2015C069I2 (de)	2024-08-08
EP1572233A1 (de)	2005-09-14
IS7885A (is)	2005-06-09
CY1111552T1 (el)	2015-08-05
TW200423957A (en)	2004-11-16
OA13147A (en)	2006-12-13
US20060251676A1 (en)	2006-11-09
EA009179B1 (ru)	2007-12-28
AR042530A1 (es)	2005-06-22
EP1572233B1 (de)	2011-03-30

Publication	Publication Date	Title
BE2019C510I2 (de)	2022-05-19
BE2018C021I2 (de)	2023-03-07
BE2017C049I2 (de)	2022-08-09
BE2017C005I2 (de)	2022-05-17
BE2016C069I2 (de)	2022-05-17
BE2016C040I2 (de)	2022-05-17
BE2016C013I2 (de)	2022-05-17
BE2015C078I2 (de)	2022-08-09
BE2016C002I2 (de)	2023-03-07
BE2018C018I2 (de)	2023-03-07
BE2015C017I2 (de)	2022-09-22
BE2014C053I2 (de)	2022-08-30
BE2014C051I2 (de)	2022-08-09
BE2014C041I2 (de)	2022-08-09
BE2014C030I2 (de)	2022-08-09
BE2014C016I2 (de)	2023-03-07
BE2014C015I2 (de)	2022-08-09
BE2013C063I2 (de)	2023-03-07
BE2013C039I2 (de)	2023-03-07
BE2011C038I2 (de)	2022-08-09
JP2003232645A5 (de)	2006-04-13
BE2015C068I2 (de)	2024-08-08
BE2013C046I2 (de)	2022-08-09
JP2003227884A5 (de)	2005-07-21
BR0315835A2 (de)	2009-01-20